PURE CALM Trademark

Trademark Overview


On Tuesday, March 13, 2018, a trademark application was filed for PURE CALM with the United States Patent and Trademark Office. The USPTO has given the PURE CALM trademark a serial number of 87832606. The federal status of this trademark filing is REGISTERED as of Tuesday, October 16, 2018. This trademark is owned by Pure Green. The PURE CALM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric dise...
pure calm

General Information


Serial Number87832606
Word MarkPURE CALM
Filing DateTuesday, March 13, 2018
Status700 - REGISTERED
Status DateTuesday, October 16, 2018
Registration Number5585603
Registration DateTuesday, October 16, 2018
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 31, 2018

Trademark Statements


Description of MarkThe mark consists of the word "PURE" and the word "CALM".
Goods and ServicesPharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention of nervousness; Pharmaceutical preparations for the treatment and prevention of nervousness; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for the treatment of nervous conditions; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations for nervousness; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Analgesic and muscle relaxant pharmaceutical preparations; Anti-epileptic pharmaceutical preparations; Balms for pharmaceutical purposes; Bandages impregnated with calming agents; Dermatological pharmaceutical products; Dextrins for pharmaceutical use; Digestives for pharmaceutical purposes; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with calming agents; Plant extracts for medical, veterinary and pharmaceutical purposes; Syringes sold filled with calming agents; Therapeutic pharmaceutical for the treatment of nervousness; Veterinary pharmaceutical preparations for the prevention of agitation; Veterinary pharmaceutical preparations for the treatment of nervousness; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 20, 2018
Primary Code005
First Use Anywhere DateThursday, February 1, 2018
First Use In Commerce DateThursday, February 1, 2018

Trademark Owner History


Party NamePure Green
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressW. Bloomfield, MI 48323

Party NamePure Green
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressW. Bloomfield, MI 48323

Party NamePure Green
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressW. Bloomfield, MI 48323

Trademark Events


Event DateEvent Description
Monday, October 16, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 16, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, July 31, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, June 24, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 23, 2018ASSIGNED TO EXAMINER
Tuesday, March 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 16, 2018NEW APPLICATION ENTERED